Abstract
The search for sensitive biomarkers for the early detection of neoplastic changes is a constant goal of cancer research. Thus, biomarkers that can be collected from body fluids, such as serum or plasma, are particularly desired, which increases the importance of studying the extracellular microRNAs present in the bloodstream. Specifically, in the case of Diffuse Large B Cell Lymphoma (DLB…